TIA
IBB icon

Tiemann Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Tiemann Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,836
Closed -$216K – 192
2022
Q2 		$216K Hold
1,836
– – 0.12% 172
2022
Q1 		$239K Hold
1,836
– – 0.11% 180
2021
Q4 		$280K Buy
+1,836
New +$284K 0.12% 171

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Tiemann Investment Advisors's IBB Position: Q3 2022 in Review

Tiemann Investment Advisors sold out of iShares Biotechnology ETF (IBB) in Q3 2022, closing a stake of 1,836 shares — an estimated $216K sold.

Tiemann Investment Advisors first reported a position in IBB in Q4 2021 and held it in 3 quarters. The position peaked at $280K in Q4 2021. 829 funds tracked by Wall St. Rank hold IBB as of Q3 2022.

  • Tiemann Investment Advisors reported no remaining iShares Biotechnology ETF position as of Q3 2022 after selling out during the quarter.
  • Tiemann Investment Advisors sold 1,836 iShares Biotechnology ETF shares in Q3 2022, an estimated $216K.
  • Tiemann Investment Advisors first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 3 quarters.
  • Tiemann Investment Advisors's iShares Biotechnology ETF position peaked at $280K in Q4 2021.
  • 829 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2022.

Based on Tiemann Investment Advisors's 13F filing for Q3 2022, filed 15 Nov 2022.